Latest intangible assets for AKER: $170K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Akers Biosciences (AKER) currently reports a intangible assets of $170K as of December 2020. That compares with $170K in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Akers Biosciences's intangible assets history and peer comparisons.
Akers Biosciences's intangible assets was unchanged from $170K to $170K — essentially flat versus a year earlier (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Akers Biosciences reported $170K in intangible assets as of December 2020. That compares with $170K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current intangible assets of $170K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Akers Biosciences, and consider following AKER for alerts when major investors trade the stock.
Akers Biosciences is classified in the Healthcare sector. On intangible assets, it currently shows $170K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AKER with unrelated industries.